PlainRecalls
FDA Drug Moderate Class II Terminated

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reported: April 10, 2019 Initiated: March 29, 2019 #D-1074-2019

Product Description

Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.

Reason for Recall

Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Details

Units Affected
12,960 bottles
Distribution
Nationwide in the USA.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg*, 90-count bottle, Rx Only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801; NDC 59746-284-90.. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 12,960 bottles.
Why was this product recalled?
Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 10, 2019. Severity: Moderate. Recall number: D-1074-2019.